Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.295
+0.035 (1.55%)
Oct 28, 2026, 10:20 AM EDT - Market open
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $448.21 million as of October 28, 2026. It is the 15,394th most valuable company in the world and the 2,823rd biggest in the United States. Its market cap has increased by 293.86% in one year.
Market Cap
448.21M
Enterprise Value
291.15M
1-Year Change
293.86%
Global Rank
Country Rank
#2,823 United States
Category
ChartMarket Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $448.21M, an increase of 48.71%. That is a compound annual growth rate of 4.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 448.21M | 286.05% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 442.94M |
| Faeth Therapeutics | 441.35M |
| REGENXBIO | 440.97M |
| Allogene Therapeutics | 431.86M |
| ProKidney | 426.27M |
| Prothena Corporation | 420.96M |
| Altimmune | 412.38M |
| Nautilus Biotechnology | 412.31M |